• Explore /
  • Poster
  • / Immunotoxin and bcl-2 inhibitor combination therapy targeting chondroitin sulfate proteoglycan 4.

Immunotoxin and bcl-2 inhibitor combination therapy targeting chondroitin sulfate proteoglycan 4.

Abstract Poster

Authors

null

Xin Yu

Duke University, Durham, NC

Xin Yu, Stephen T. Keir, Scott Szafranski, Steven Clayton, Ira Pastan, Darell D. Bigner, Vidyalakshmi Chandramohan

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO-SITC Clinical Immuno-Oncology Symposium

Session Type

Poster Session

Session Title

Poster Session A

Track

Biomarkers and Inflammatory Signatures,Humoral Immunity for Diagnosis and Therapy,Immune Checkpoints and Stimulatory Receptors,Modulating Innate Immunity,Therapies Targeting T cells

Sub Track

B-cell-Directed Therapy

Citation

J Clin Oncol 35, 2017 (suppl 7S; abstract 74)

DOI

10.1200/JCO.2017.35.7_suppl.74

Abstract #

74

Poster Bd #

C7

Abstract Disclosures

Similar Posters

Poster

2015 ASCO Annual Meeting

Immunotoxin therapy in animal model of HuD antigen positive small cell lung cancer.

Immunotoxin therapy in animal model of HuD antigen positive small cell lung cancer.

First Author: Bo Wang

First Author: Hafiz Khuram Raza

First Author: Guillermo De Velasco

First Author: Jun Guo